Abstract: A method for detecting communication loop in an ad hoc network is provided. The method may comprise: receiving, at a node of the ad hoc network, a message comprising a commutative value, wherein the node is associated with a node identifier and the commutative value pertains to node identifiers associated with one or more nodes along a path the message has been traversed along regardless of the order of the nodes; and determining, with aid of one or more processors, presence of a loop based on whether the commutative value is identical to a previously obtained commutative value.

Abstract: The present invention relates to an improved process for isolating a carotenoid from a carotenoid-producing bioorganism, as well as to a formulation comprising such a carotenoid, and the use of such a solid formulation in feed products (or pre-mixes).

Abstract: The present invention relates to an improved process for isolating a carotenoid from a carotenoid-producing bioorganism, as well as to a formulation comprising such a carotenoid, and the use of such a solid formulation in feed products (or pre-mixes).

Abstract: The present invention relates to a solid formulation comprising a carotenoid producing source bioorganism, which is storage stable, as well as the process of production of this formulation.

Abstract: The present invention relates to diphenyloxyalkylamine derivatives and aryloxyalkylamine derivatives that are structurally analogous to mexiletine, said derivatives having important biological activity and not causing the undesired side effects observed with the prototype, as well as with other drugs from the same therapeutic class as the prototype. The derivatives of the present invention have formulas II and III and are used for treating, preventing or inhibiting pulmonary inflammatory diseases, for example, asthma and chronic obstructive pulmonary disease (COPD).

Abstract: The present invention provides methods of identifying subjects that are suitable and not suitable for high-dose cyclophosphamide treatment.

Abstract: A high-capacity SIM card includes: memory having at least one partition and a memory controller configured: to control at least two modes of access to one partition of the partitions, only one of the modes being a currently-active mode; and to allow the currently-active mode to be operationally changed remotely. Preferably, the memory controller controls operability of reading data, writing data, erasing data, and/or executing code, according to the currently-active mode. Preferably, the memory controller also controls storage of data in the card based on access-control data delivered to the card. Preferably, the memory controller is configured to reversibly operationally change, for one partition, which mode is the currently-active mode. Preferably, the memory controller prohibits change of the currently-active mode by a host device of the card.

Abstract: The present invention provides methods of treating subjects with an oxazaphosphorines, methods of identifying subjects that are suitable for oxazaphosphorine treatment, and systems for ensuring the safety and efficacy of a treatment that includes oxazaphosphorine administration.

Abstract: The present invention relates to methods of treating cancer with a cancer vaccine using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a biomarker; methods of prognosticating an outcome of cancer treatment with a cancer vaccine using GM-CSF as a biomarker; methods for qualifying subjects for cancer vaccination using GM-CSF as a biomarker; methods for comparing the efficacy of two or more cancer vaccine treatments based on GM-CSF response; and kits for the effective treatment of cancer.

Abstract: A device for generating electrical energy by harnessing the energy of waves includes an enveloping housing (1) divided into: a lower air chamber (23) containing a generator (14) and a high tonnage weight (12), suspended from an upper axle (10) mechanically connected to a lower axle (16); an intermediate chamber (24) that includes water inlets/outlets (22) and is open at the top by means of an air outlet (29); and an upper chamber (25) including a compressor (6), a turbine (4) and a generator (5). The compressor (6) is mechanically actuated by an electric motor or by mechanical transmission by a chain (7) connecting the upper axle (10) of the lower chamber (23) and the axle of the compressor (6), and generates pressurized air for removing the water from the intermediate chamber (24).

Abstract: The present invention relates to methods of treating a cancer and in particular, a B-cell derived cancer, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug in combination with immune therapeutics such as, for example, an autologous idiotypic vaccine and monoclonal antibodies that selectively bind B-cell specific antigens.

Abstract: Various methods, devices and systems are described for providing distributed storage services. A data storage device is capable of initiating a communication session with an external entity such as a local host computer (and vice versa) coupled directly to the data storage device, a remote server computer, or directly with remote data storage devices with or without intervention by a local host computer.

Abstract: A device for generating electrical energy by harnessing the energy of waves includes an enveloping housing (1) divided into: a lower air chamber (23) containing a generator (14) and a high tonnage weight (12), suspended from an upper axle (10) mechanically connected to a lower axle (16); an intermediate chamber (24) that includes water inlets/outlets (22) and is open at the top by means of an air outlet (29); and an upper chamber (25) including a compressor (6), a turbine (4) and a generator (5). The compressor (6) is mechanically actuated by an electric motor or by mechanical transmission by a chain (7) connecting the upper axle (10) of the lower chamber (23) and the axle of the compressor (6), and generates pressurised air for removing the water from the intermediate chamber (24).

Abstract: A gastroretentive composition comprises a mixture comprising an active ingredient component and an excipient component. The excipient component comprises a first water-soluble reaction product produced from a precursor comprising a vinyl group, and a copolymer of a polyalkylene glycol and a second water-soluble reaction product produced from a precursor comprising a vinyl group. A method of forming the gastroretentive composition comprises the steps of providing the active ingredient component and the excipient component, and mixing the active ingredient component and the excipient component to form a mixture. The mixture is aggregated to form an aggregation that is dry granulated to form a plurality of granules. The plurality of granules is processed to form the gastroretentive composition.